Journal of Biopharmaceutical Statistics

SJR Rank #8,529H-index: 60SJR: 0.680Best quartile: Q2
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United States

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • PharmacologyQ2
  • Pharmacology (medical)Q2
  • Statistics and ProbabilityQ2

Areas: Mathematics · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Statistical Methods in Clinical TrialsOptimal Experimental Design MethodsStatistical Methods and Bayesian InferenceStatistical Methods and InferenceHealth Systems, Economic Evaluations, Quality of LifeAdvanced Causal Inference TechniquesMeta-analysis and systematic reviewsComputational Drug Discovery MethodsAdvanced Statistical Methods and ModelsBiosimilars and Bioanalytical Methods

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs055110165220

Documents per Year

2022202504080120160

Detailed Information

ISSN

1054-3406, 1520-5711

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

1.26

References per Document

30.10

Coverage

1991-2026

Scope

The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to biopharmaceutical research in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers: Drug, device, and biological research and development; Drug screening and drug design; Assessment of pharmacological activity; Pharmaceutical formulation and scale-up; Preclinical safety assessment; Bioavailability, bioequivalence, and pharmacokinetics; Phase, I, II, and III clinical development including complex innovative designs; Premarket approval assessment of clinical safety; Postmarketing surveillance; Big data and artificial intelligence and applications.

Metrics from SCImago Journal Rank 2025. View on SCImago